Personalized combination therapies for cancer patients.
Researchers at Stanford took blood samples from patients and sent them to Chicago-based Tempus for genomic sequencing of the person’s cancer. Another sample was sent to Notable, which used its AI-based automated laboratory system to test hundreds of potential drug treatments against the disease and provided treatment recommendations based on that analysis. Stanford clinicians then used this data (alongside the clinical features of the patient) to create a report with individualized recommendations that could inform future treatment.
The partnership between for-profit Notable Labs and nonprofit Cures Within Reach could bring a childhood cancer treatment — a combination discovered by Foster City's Notable Labs of a generic drug and a natural product — to market faster and cheaper.
CEO Matt De Silva and his team at Notable Labs reveal the story behind their mission to provide individualized cancer therapy using the Echo Acoustic Liquid Handling technology.
Labcyte Inc. and Notable Labs today announced a collaboration to apply the unique capabilities of Labcyte’s revolutionary Echo® acoustic liquid handling technology to screen individual cancer patients’ tumor cells.
Notable Labs is building on the idea of personalized medicine and using a patient’s own cancer cells to guide therapy.